AGENUS INC (AGEN) Stock News

USA - NASDAQ:AGEN - US00847G8042 - Common Stock

4.125 USD

-0.11 (-2.48%)

Last: 11/19/2025, 11:23:46 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AGEN Latest News, Press Relases and Analysis

All

Press Releases

9 days ago - By: Chartmill

News Image

AGENUS INC (NASDAQ:AGEN) Reports Mixed Q3 2025 Earnings, Driven by One-Time Gain

a day ago - By: Agenus Inc.

Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC

9 days ago - By: Zacks Investment Research - Mentions: ARMP

Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates

9 days ago - By: Agenus Inc.

Agenus Reports Q3 2025 Results Showcasing Clinical and Regulatory Advances

12 days ago - By: Benzinga

Insights Ahead: Agenus's Quarterly Earnings

13 days ago - By: Zacks Investment Research - Mentions: NTLA

Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Misses Revenue Estimates

14 days ago - By: Zacks Investment Research - Mentions: INVA

Innoviva (INVA) Q3 Earnings and Revenues Beat Estimates

14 days ago - By: Agenus Inc.

Agenus to Provide Corporate Update and Third Quarter 2025 Financial Report

16 days ago - By: Zacks Investment Research - Mentions: SRPT

Sarepta Therapeutics (SRPT) Reports Q3 Loss, Beats Revenue Estimates

a month ago - By: Agenus Inc.

Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025

a month ago - By: Agenus Inc.

Agenus to Host October Stakeholder Briefing Showcasing BOT/BAL Global Momentum and Post-ESMO Insights

2 months ago - By: Agenus Inc.

France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

3 months ago - By: Agenus, Inc.

Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Agenus Inc.

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

3 months ago - By: Agenus Inc.

Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025

3 months ago - By: Zacks Investment Research - Mentions: INO

Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates

3 months ago - By: The Motley Fool

Agenus Posts 48% Q2 Revenue Miss

3 months ago - By: Agenus Inc.

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

3 months ago - By: Benzinga

Examining the Future: Agenus's Earnings Outlook

3 months ago - By: Zacks Investment Research - Mentions: GILD

Gilead Sciences (GILD) Tops Q2 Earnings and Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: ANAB

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates

4 months ago - By: Zacks Investment Research - Mentions: CVEO QS

Zacks.com featured highlights include QuantumScape, Civeo and Agenus

4 months ago - By: Agenus Inc.

Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report

4 months ago - By: Agenus Inc.

Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025

5 months ago - By: Agenus Inc.

Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3

5 months ago - By: Agenus Inc.

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

5 months ago - By: Yahoo Finance - Mentions: TIXT TINT TU CLVT

TELUS International (Cda) Inc. (TIXT) Surges 27% Following Buyout Proposal from TELUS Corporation

5 months ago - By: Yahoo Finance - Mentions: SNYR SYNR MKL BTG ...

Here is What You Need to Know Before Investing in Synergy CHC Corp. (SNYR)

5 months ago - By: Yahoo Finance - Mentions: HON ITGR TTEK FSS ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

5 months ago - By: Agenus Inc.

Agenus Announces Virtual Annual Shareholders Meeting